<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>333 其他錐體外疾病及不正常動作疾患</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>333-其他錐體外疾病及不正常動作疾患</caption>
<thead><tr><th>ICD 333</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>333</td><td>Ferritin, light chain</td><td>19q13.33</td><td>FTL, NBIA3, LFTD</td><td><a href="https://www.omim.org/entry/134790?search=134790" target="_blank">134790</a></td><td><a href="https://www.omim.org/entry/606159?search=606159" target="_blank">606159</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>NK2 homeobox 1</td><td>14q13.3</td><td>NKX2-1, TITF1, NKX2A, TTF1, NMTC1</td><td><a href="https://www.omim.org/entry/600635?search=600635" target="_blank">600635</a></td><td><a href="https://www.omim.org/entry/118700?search=118700" target="_blank">118700</a></td><td>YES</td><td>YES</td><td>TTF1:LRRC75B(chr22:24592953)</td></tr>
<tr class='oddrow'><td>333</td><td>Restless legs syndrome, susceptibility to, 1</td><td>12q12-q21</td><td>RLS1</td><td><a href="https://www.omim.org/entry/102300?search=102300" target="_blank">102300</a></td><td><a href="https://www.omim.org/entry/102300?search=102300" target="_blank">102300</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Restless legs syndrome, susceptibility to, 6</td><td>6p21</td><td>RLS6</td><td><a href="https://www.omim.org/entry/611185?search=611185" target="_blank">611185</a></td><td><a href="https://www.omim.org/entry/611185?search=611185" target="_blank">611185</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Basal ganglia calcification, idiopathic, 2</td><td>2q37</td><td>IBGC2</td><td><a href="https://www.omim.org/entry/606656?search=606656" target="_blank">606656</a></td><td><a href="https://www.omim.org/entry/606656?search=606656" target="_blank">606656</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Kell blood group precursor</td><td>Xp21.1</td><td>XK, MCLDS</td><td><a href="https://www.omim.org/entry/314850?search=314850" target="_blank">314850</a></td><td><a href="https://www.omim.org/entry/300842?search=300842" target="_blank">300842</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>DOPA decarboxylase (aromatic L-amino acid decarboxylase)</td><td>7p12.2-p12.1</td><td>DDC</td><td><a href="https://www.omim.org/entry/107930?search=107930" target="_blank">107930</a></td><td><a href="https://www.omim.org/entry/608643?search=608643" target="_blank">608643</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Protein kinase, interferon-inducible double-stranded RNA-dependent activator</td><td>2q31.2</td><td>PRKRA, PACT, RAX, DYT16</td><td><a href="https://www.omim.org/entry/603424?search=603424" target="_blank">603424</a></td><td><a href="https://www.omim.org/entry/612067?search=612067" target="_blank">612067</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Phospholipase A2, group VI</td><td>22q13.1</td><td>PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14</td><td><a href="https://www.omim.org/entry/603604?search=603604" target="_blank">603604</a></td><td><a href="https://www.omim.org/entry/256600?search=256600" target="_blank">256600</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Restless legs syndrome, susceptibility to, 4</td><td>2q33</td><td>RLS4</td><td><a href="https://www.omim.org/entry/610439?search=610439" target="_blank">610439</a></td><td><a href="https://www.omim.org/entry/610439?search=610439" target="_blank">610439</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>GTP cyclohydrolase 1</td><td>14q22.2</td><td>GCH1, DYT5, HPABH4B</td><td><a href="https://www.omim.org/entry/600225?search=600225" target="_blank">600225</a></td><td><a href="https://www.omim.org/entry/128230?search=128230" target="_blank">128230</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>THAP domain-containing protein 1</td><td>8p11.21</td><td>THAP1, DYT6</td><td><a href="https://www.omim.org/entry/609520?search=609520" target="_blank">609520</a></td><td><a href="https://www.omim.org/entry/602629?search=602629" target="_blank">602629</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Supranuclear palsy, progressive, 3</td><td>11p12-p11</td><td>PSNP3</td><td><a href="https://www.omim.org/entry/610898?search=610898" target="_blank">610898</a></td><td><a href="https://www.omim.org/entry/610898?search=610898" target="_blank">610898</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Geniospasm 1</td><td>9q13-q21</td><td>GSM1, GSP</td><td><a href="https://www.omim.org/entry/190100?search=190100" target="_blank">190100</a></td><td><a href="https://www.omim.org/entry/190100?search=190100" target="_blank">190100</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Nucleolar protein 3</td><td>16q22.1</td><td>NOL3, NOP, MYC, ARC, FCM</td><td><a href="https://www.omim.org/entry/605235?search=605235" target="_blank">605235</a></td><td><a href="https://www.omim.org/entry/614937?search=614937" target="_blank">614937</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD</td><td>Xq13.1</td><td>TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33</td><td><a href="https://www.omim.org/entry/313650?search=313650" target="_blank">313650</a></td><td><a href="https://www.omim.org/entry/314250?search=314250" target="_blank">314250</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Pantothenate kinase 2</td><td>20p13</td><td>PANK2, NBIA1, PKAN, HARP</td><td><a href="https://www.omim.org/entry/606157?search=606157" target="_blank">606157</a></td><td><a href="https://www.omim.org/entry/234200?search=234200" target="_blank">234200</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Platelet-derived growth factor, beta polypeptide (oncogene SIS)</td><td>22q13.1</td><td>PDGFB, SIS, IBGC5</td><td><a href="https://www.omim.org/entry/190040?search=190040" target="_blank">190040</a></td><td><a href="https://www.omim.org/entry/615483?search=615483" target="_blank">615483</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Restless legs syndrome, susceptibility to, 7</td><td>2p14-p13</td><td>RLS7</td><td><a href="https://www.omim.org/entry/612853?search=612853" target="_blank">612853</a></td><td><a href="https://www.omim.org/entry/612853?search=612853" target="_blank">612853</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Dystonia-17, primary torsion</td><td>20p11.2-q13.12</td><td>DYT17</td><td><a href="https://www.omim.org/entry/612406?search=612406" target="_blank">612406</a></td><td><a href="https://www.omim.org/entry/612406?search=612406" target="_blank">612406</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Phospholipase A2, group VI</td><td>22q13.1</td><td>PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14</td><td><a href="https://www.omim.org/entry/603604?search=603604" target="_blank">603604</a></td><td><a href="https://www.omim.org/entry/612953?search=612953" target="_blank">612953</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Nucleoporin, 62-kD</td><td>19q13.33</td><td>NUP62, SNDI, IBSN</td><td><a href="https://www.omim.org/entry/605815?search=605815" target="_blank">605815</a></td><td><a href="https://www.omim.org/entry/271930?search=271930" target="_blank">271930</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Dystonia 13, torsion</td><td>1p36.32-p36.13</td><td>DYT13</td><td><a href="https://www.omim.org/entry/607671?search=607671" target="_blank">607671</a></td><td><a href="https://www.omim.org/entry/607671?search=607671" target="_blank">607671</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Calcium channel, voltage-dependent, L type, alpha 1B subunit</td><td>9q34.3</td><td>CACNA1B, CACNL1A5, DYT23</td><td><a href="https://www.omim.org/entry/601012?search=601012" target="_blank">601012</a></td><td><a href="https://www.omim.org/entry/614860?search=614860" target="_blank">614860</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>WD repeat-containing protein 45</td><td>Xp11.23</td><td>WDR45, WIPI4, NBIA5</td><td><a href="https://www.omim.org/entry/300526?search=300526" target="_blank">300526</a></td><td><a href="https://www.omim.org/entry/300894?search=300894" target="_blank">300894</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Chromosome 19 open reading frame 12</td><td>19q12</td><td>C19orf12, NBIA4, SPG43</td><td><a href="https://www.omim.org/entry/614297?search=614297" target="_blank">614297</a></td><td><a href="https://www.omim.org/entry/614298?search=614298" target="_blank">614298</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Phospholipase A2, group VI</td><td>22q13.1</td><td>PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14</td><td><a href="https://www.omim.org/entry/603604?search=603604" target="_blank">603604</a></td><td><a href="https://www.omim.org/entry/610217?search=610217" target="_blank">610217</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Phosphodiesterase 8B</td><td>5q13.3</td><td>PDE8B, PPNAD3, ADSD</td><td><a href="https://www.omim.org/entry/603390?search=603390" target="_blank">603390</a></td><td><a href="https://www.omim.org/entry/609161?search=609161" target="_blank">609161</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Potassium channel tetramerization domain-containing protein 17</td><td>22q12.3</td><td>KCTD17</td><td><a href="https://www.omim.org/entry/616386?search=616386" target="_blank">616386</a></td><td><a href="https://www.omim.org/entry/616398?search=616398" target="_blank">616398</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Junctophilin 3</td><td>16q24.2</td><td>JPH3, JP3, HDL2</td><td><a href="https://www.omim.org/entry/605268?search=605268" target="_blank">605268</a></td><td><a href="https://www.omim.org/entry/606438?search=606438" target="_blank">606438</a></td><td>YES</td><td>YES</td><td>JPH3:SMG6(chr17:2188471)</td></tr>
<tr class='oddrow'><td>333</td><td>17-beta-hydroxysteroid dehydrogenase X</td><td>Xp11.22</td><td>HSD17B10, HADH2, ERAB, MRXS10, HSD10MD</td><td><a href="https://www.omim.org/entry/300256?search=300256" target="_blank">300256</a></td><td><a href="https://www.omim.org/entry/300438?search=300438" target="_blank">300438</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Platelet-derived growth factor receptor, beta polypeptide</td><td>5q32</td><td>PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS</td><td><a href="https://www.omim.org/entry/173410?search=173410" target="_blank">173410</a></td><td><a href="https://www.omim.org/entry/615007?search=615007" target="_blank">615007</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>N-acylsphingosine amidohydrolase (acid ceramidase) 1</td><td>8p22</td><td>ASAH1, AC, SMAPME</td><td><a href="https://www.omim.org/entry/613468?search=613468" target="_blank">613468</a></td><td><a href="https://www.omim.org/entry/159950?search=159950" target="_blank">159950</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Sepiapterin reductase</td><td>2p13.2</td><td>SPR</td><td><a href="https://www.omim.org/entry/182125?search=182125" target="_blank">182125</a></td><td><a href="https://www.omim.org/entry/612716?search=612716" target="_blank">612716</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Anoctamin 3</td><td>11p14.3-p14.2</td><td>ANO3, TMEM16C, C11orf25, DYT24</td><td><a href="https://www.omim.org/entry/610110?search=610110" target="_blank">610110</a></td><td><a href="https://www.omim.org/entry/615034?search=615034" target="_blank">615034</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/215450?search=215450" target="_blank">215450</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Restless legs syndrome, susceptibility to, 8</td><td>5q31</td><td>RLS8</td><td><a href="https://www.omim.org/entry/615197?search=615197" target="_blank">615197</a></td><td><a href="https://www.omim.org/entry/615197?search=615197" target="_blank">615197</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Dopamine receptor D3</td><td>3q13.31</td><td>DRD3, ETM1, FET1</td><td><a href="https://www.omim.org/entry/126451?search=126451" target="_blank">126451</a></td><td><a href="https://www.omim.org/entry/190300?search=190300" target="_blank">190300</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Guanine nucleotide-binding protein, alpha-subunit, olfactory type</td><td>18p11.21</td><td>GNAL, DYT25</td><td><a href="https://www.omim.org/entry/139312?search=139312" target="_blank">139312</a></td><td><a href="https://www.omim.org/entry/615073?search=615073" target="_blank">615073</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial)</td><td>4q21.22-q21.23</td><td>COQ2, COQ10D1, MSA1</td><td><a href="https://www.omim.org/entry/609825?search=609825" target="_blank">609825</a></td><td><a href="https://www.omim.org/entry/146500?search=146500" target="_blank">146500</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>ATPase, type 13A2</td><td>1p36.13</td><td>ATP13A2, PARK9, KRPPD, SPG78</td><td><a href="https://www.omim.org/entry/610513?search=610513" target="_blank">610513</a></td><td><a href="https://www.omim.org/entry/606693?search=606693" target="_blank">606693</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Torsin A</td><td>9q34.11</td><td>DYT1, TOR1A</td><td><a href="https://www.omim.org/entry/605204?search=605204" target="_blank">605204</a></td><td><a href="https://www.omim.org/entry/128100?search=128100" target="_blank">128100</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Paroxysmal nonkinesigenic dyskinesia 2</td><td>2q31</td><td>PNKD2</td><td><a href="https://www.omim.org/entry/611147?search=611147" target="_blank">611147</a></td><td><a href="https://www.omim.org/entry/611147?search=611147" target="_blank">611147</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Restless legs syndrome, susceptibility to, 3</td><td>9p24-p22</td><td>RLS3</td><td><a href="https://www.omim.org/entry/610438?search=610438" target="_blank">610438</a></td><td><a href="https://www.omim.org/entry/610438?search=610438" target="_blank">610438</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/184850?search=184850" target="_blank">184850</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/500003?search=500003" target="_blank">500003</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Ceruloplasmin</td><td>3q24-q25</td><td>CP</td><td><a href="https://www.omim.org/entry/117700?search=117700" target="_blank">117700</a></td><td><a href="https://www.omim.org/entry/604290?search=604290" target="_blank">604290</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Supranuclear palsy, progressive, 2</td><td>1q31.1</td><td>PSNP2</td><td><a href="https://www.omim.org/entry/609454?search=609454" target="_blank">609454</a></td><td><a href="https://www.omim.org/entry/609454?search=609454" target="_blank">609454</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/602554?search=602554" target="_blank">602554</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Dopamine receptor D5</td><td>4p16.1</td><td>DRD5, DRD1B, DRD1L2</td><td><a href="https://www.omim.org/entry/126453?search=126453" target="_blank">126453</a></td><td><a href="https://www.omim.org/entry/606798?search=606798" target="_blank">606798</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Restless legs syndrome, susceptibility to, 5</td><td>20p13</td><td>RLS5</td><td><a href="https://www.omim.org/entry/611242?search=611242" target="_blank">611242</a></td><td><a href="https://www.omim.org/entry/611242?search=611242" target="_blank">611242</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Microtubule-associated protein tau</td><td>17q21.31</td><td>MAPT, MTBT1, DDPAC, MSTD</td><td><a href="https://www.omim.org/entry/157140?search=157140" target="_blank">157140</a></td><td><a href="https://www.omim.org/entry/260540?search=260540" target="_blank">260540</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Sarcoglycan, epsilon</td><td>7q21.3</td><td>SGCE, DYT11</td><td><a href="https://www.omim.org/entry/604149?search=604149" target="_blank">604149</a></td><td><a href="https://www.omim.org/entry/159900?search=159900" target="_blank">159900</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Prion protein (p27-30)</td><td>20p13</td><td>PRNP, PRIP, KURU, CJD</td><td><a href="https://www.omim.org/entry/176640?search=176640" target="_blank">176640</a></td><td><a href="https://www.omim.org/entry/603218?search=603218" target="_blank">603218</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Tremor, hereditary essential, 2</td><td>2p25-p22</td><td>ETM2, ETM</td><td><a href="https://www.omim.org/entry/602134?search=602134" target="_blank">602134</a></td><td><a href="https://www.omim.org/entry/602134?search=602134" target="_blank">602134</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Myofibrillogenesis regulator 1</td><td>2q35</td><td>MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8</td><td><a href="https://www.omim.org/entry/609023?search=609023" target="_blank">609023</a></td><td><a href="https://www.omim.org/entry/118800?search=118800" target="_blank">118800</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Tubulin, beta-4A</td><td>19p13.3</td><td>TUBB4A, DYT4, HLD6</td><td><a href="https://www.omim.org/entry/602662?search=602662" target="_blank">602662</a></td><td><a href="https://www.omim.org/entry/128101?search=128101" target="_blank">128101</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Collagen VI, alpha-3 polypeptide</td><td>2q37.3</td><td>COL6A3, DYT27, BTHLM1, UCMD1</td><td><a href="https://www.omim.org/entry/120250?search=120250" target="_blank">120250</a></td><td><a href="https://www.omim.org/entry/616411?search=616411" target="_blank">616411</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Dystonia 21</td><td>2q14.3-q21.3</td><td>DYT21</td><td><a href="https://www.omim.org/entry/614588?search=614588" target="_blank">614588</a></td><td><a href="https://www.omim.org/entry/614588?search=614588" target="_blank">614588</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Tyrosine hydroxylase</td><td>11p15.5</td><td>TH, TYH</td><td><a href="https://www.omim.org/entry/191290?search=191290" target="_blank">191290</a></td><td><a href="https://www.omim.org/entry/605407?search=605407" target="_blank">605407</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Tremor, hereditary essential, 3</td><td>6p23</td><td>ETM3</td><td><a href="https://www.omim.org/entry/611456?search=611456" target="_blank">611456</a></td><td><a href="https://www.omim.org/entry/611456?search=611456" target="_blank">611456</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>333</td><td>Coenzyme A synthase</td><td>17q21.2</td><td>COASY, NBIA6</td><td><a href="https://www.omim.org/entry/609855?search=609855" target="_blank">609855</a></td><td><a href="https://www.omim.org/entry/615643?search=615643" target="_blank">615643</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Solute carrier family 2 (facilitated glucose transporter), member 1</td><td>1p34.2</td><td>SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN</td><td><a href="https://www.omim.org/entry/138140?search=138140" target="_blank">138140</a></td><td><a href="https://www.omim.org/entry/612126?search=612126" target="_blank">612126</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Hippocalcin, 23kD, Ca2+-binding protein</td><td>1p35.1</td><td>HPCA, DYT2</td><td><a href="https://www.omim.org/entry/142622?search=142622" target="_blank">142622</a></td><td><a href="https://www.omim.org/entry/224500?search=224500" target="_blank">224500</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Xenotropic and polytropic retrovirus receptor</td><td>1q25.3</td><td>XPR1, SYG1, IBGC6</td><td><a href="https://www.omim.org/entry/605237?search=605237" target="_blank">605237</a></td><td><a href="https://www.omim.org/entry/616413?search=616413" target="_blank">616413</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Solute carrier family 2 (facilitated glucose transporter), member 1</td><td>1p34.2</td><td>SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN</td><td><a href="https://www.omim.org/entry/138140?search=138140" target="_blank">138140</a></td><td><a href="https://www.omim.org/entry/601042?search=601042" target="_blank">601042</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for)</td><td>8p11.21</td><td>SLC20A2, MLVAR, GLVR2, IBGC1</td><td><a href="https://www.omim.org/entry/158378?search=158378" target="_blank">158378</a></td><td><a href="https://www.omim.org/entry/213600?search=213600" target="_blank">213600</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Fusion, derived from 12-16 translocation, malignant liposarcoma</td><td>16p11.2</td><td>FUS, TLS, ALS6, ETM4</td><td><a href="https://www.omim.org/entry/137070?search=137070" target="_blank">137070</a></td><td><a href="https://www.omim.org/entry/614782?search=614782" target="_blank">614782</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Huntingtin</td><td>4p16.3</td><td>HTT, HD, IT15, LOMARS</td><td><a href="https://www.omim.org/entry/613004?search=613004" target="_blank">613004</a></td><td><a href="https://www.omim.org/entry/143100?search=143100" target="_blank">143100</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>ATPase, Na+K+ transporting, alpha-3 polypeptide</td><td>19q13.2</td><td>ATP1A3, DYT12, RDP, AHC2, CAPOS</td><td><a href="https://www.omim.org/entry/182350?search=182350" target="_blank">182350</a></td><td><a href="https://www.omim.org/entry/128235?search=128235" target="_blank">128235</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Fatty acid 2-hydroxylase</td><td>16q23.1</td><td>FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35</td><td><a href="https://www.omim.org/entry/611026?search=611026" target="_blank">611026</a></td><td><a href="https://www.omim.org/entry/612319?search=612319" target="_blank">612319</a></td><td></td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Episodic kinesigenic dyskinesia 2</td><td>16q13-q22.1</td><td>EKD2</td><td><a href="https://www.omim.org/entry/611031?search=611031" target="_blank">611031</a></td><td><a href="https://www.omim.org/entry/611031?search=611031" target="_blank">611031</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Proline-rich transmembrane protein 2</td><td>16p11.2</td><td>PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA</td><td><a href="https://www.omim.org/entry/614386?search=614386" target="_blank">614386</a></td><td><a href="https://www.omim.org/entry/128200?search=128200" target="_blank">128200</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Aristaless-related homeobox, X-linked</td><td>Xp21.3</td><td>ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32</td><td><a href="https://www.omim.org/entry/300382?search=300382" target="_blank">300382</a></td><td><a href="https://www.omim.org/entry/308350?search=308350" target="_blank">308350</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>333</td><td>Microtubule-associated protein tau</td><td>17q21.31</td><td>MAPT, MTBT1, DDPAC, MSTD</td><td><a href="https://www.omim.org/entry/157140?search=157140" target="_blank">157140</a></td><td><a href="https://www.omim.org/entry/601104?search=601104" target="_blank">601104</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr><td>333</td><td>Huntington disease-like 3</td><td>4p15.3</td><td>HDL3, HLN2</td><td><a href="https://www.omim.org/entry/604802?search=604802" target="_blank">604802</a></td><td><a href="https://www.omim.org/entry/604802?search=604802" target="_blank">604802</a></td><td></td><td>YES</td><td></td></tr>
</tbody></table>
</body>
</html>
